Skip to main content
Livermore
Livermore
ZHEN

MAIA Biotechnology, Inc.

MAIA
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001878313

In the last 90 days, MAIA Biotechnology, Inc. insiders filed 5 open-market purchases and 0 sales; 36 institutions reported holding it in 13F filings for Q2 2026, worth $19.4M in total; no superinvestor holds it.

Holders of 5% or more of MAIA

Holders whose latest Schedule 13D or 13G filing reports 5% or more of MAIA Biotechnology, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of MAIA
HolderLatest formStakeChangeFirst filedLatest filingFiling
FGMK Business Holdings, LLC13G9.99%2.89M sharesNewMar 3, 20251 filingMar 3, 2025SEC
Vitoc Vlad13D/A9.66%3.85M shares–Dec 4, 20251 filingDec 4, 2025SEC
Solas Capital Management, LLC13G7.10%4.30M sharesNewMay 15, 20261 filingMay 15, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

4 Schedule 13D and 13G filings on MAIA Biotechnology, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on MAIA
Filed (ET)FilerFormStakeChangeEvent dateFiling
May 15, 202611:06 AM ETSolas Capital Management, LLCand 1 other13G7.10%4.30M sharesNewMar 31, 2026SEC
Dec 4, 20254:05 PM ETVitoc Vlad13D/A9.66%3.85M shares–Nov 21, 2025SEC
Mar 3, 20255:28 PM ETFGMK Business Holdings, LLCand 1 other13G9.99%2.89M sharesNewSep 14, 2024SEC
Feb 14, 20255:27 PM ETGryaznov Sergei13G/A4.08%1.14M shares–Below 5%Dec 31, 2023SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell MAIA Biotechnology, Inc. shares.

No Form 144 notices for MAIA Biotechnology, Inc. are on file.